Intermediate Name | Technical Package | USA secondary DMF | CANADA secondary DMF |
---|---|---|---|
Betamethasone base | √ | ||
canrenone | |||
Desoxycortisone base & acetate | √ | ||
Dexamethasone base | √ | ||
Diflorasone base | √ | ||
Flumethasone base | √ | √ | √ |
Sirolimus | |||
Staurosporine (int of Midostaurin) | √ | √ | |
Tetraene Acetate(3TR) | √ | ||
16 Alpha Hydroxyl Prednisolone (Budesonide &Ciclesonideint) | √ | √ | √ |
16 Alpha-Methyl Epoxide (8-DM) | √ | √ | |
16 Beta-Methyl Epoxide (DB-11) | √ | √ | |
10-DAB (10-DeacetylbaccatinⅢ) | √ | √ | |
PAX100(565456-77-1)methyl(1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate hydrochloride | √ | ||
PAX160(2628280-48-6)(S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanamidehydrochloride | √ | ||
PX105(62965-35-9)(S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoicacid | √ |
※ Disclaimer:
Products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area wherethe sale of such products constitutes a patent infringement.Any liability is at buyer's risk.